Uptake of intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria during pregnancy and pregnancy outcomes: a cross-sectional study in Geita district, North-Western Tanzania

Table 7 Secondary analysis of factors associated with pre-term delivery among delivering women

Variable	Pre-term delivery^§		Crude OR	P-value	Adjusted OR	P-value
	N	No. PTD (%)	(95% CI)		(95% CI)
Maternal age
<20 years	97	21 (21.65)	2.22 (1.23, 4.01)	0.008	2.92 (1.12, 7.65)	0.029
≥20 years	334	37 (11.08)	Reference		Reference
Health facility
Geita hospital	265	25 (9.43)	Reference		Reference
Katoro HC	166	33 (19.88)	2.38 (1.36, 4.18)	0.002	2.02 (0.65, 6.35)	0.227
Peripheral malaria
Positive	128	19 (14.84)	1.18 (0.65, 2.13)	0.584	0.36 (0.11, 1.10)	0.073
Negative	303	39 (12.87)	Reference		Reference
Level of education
None/Primary	360	53 (14.72)	2.28 (0.88, 5.92)	0.091	1.69 (0.45, 6.33)	0.439
Secondary/Higher	71	5 (7.04)	Reference		Reference
Placental malaria
Positive	162	33 (20.37)	2.50 (1.42, 4.38)	0.001	4.67 (1.74, 12.58)	0.002
Negative	269	25 (9.25)	Reference		Reference
MIP by RDT
Positive	84	16 (19.05)	1.71 (0.91, 3.22)	0.097	2.13 (0.69, 6.59)	0.188
Negative	347	42 (12.10)	Reference		Reference
SP receipt
<3 doses	405	55 (13.58)	Reference		Reference
≥3 doses	26	3 (11.54)	0.83 (0.24, 2.86)	0.768	0.55 (0.13, 2.33)	0.416
Last SP time lapse
≤4 weeks	26	14 (53.85)	0.47 (0.21, 1.06)	0.069	0.38 (0.15, 0.97)	0.042
>4 weeks	238	170 (71.43)	Reference		Reference

HC = health centre; RDT = rapid diagnostic test, MIP = malaria in pregnancy, PTD = pre-term delivery, § = Assessed by first day of last menstrual period or by New Ballard Score; Significant p-values are presented in bold.

ISSN: 1475-2875